Log In
BCIQ
Print this Print this
 

APG880

  Manage Alerts
Collapse Summary General Information
Company Apogenix AG
DescriptionHuman Fc-fusion protein consisting of two single chain tumour necrosis factor related apoptosis inducing ligand (TRAIL)-molecules fused to an Fc-part of a human IgG molecule
Molecular Target Tumor necrosis factor (TNF)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerAbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today